Status: retired, Primitive. Date: 30-Jun 2023. Module: Australian Medicines Terminology module
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
1433841000168110 | Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
1433851000168112 | Ropivacaine 0.2% (Kabi) 20 mg/10 mL injection solution, 10 mL ampoule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | has intended active ingredient | ropivacaine | false | Inferred relationship | Some | 1175315839 | |
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | Is a | trade product unit of use | false | Inferred relationship | Some | ||
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | Is a | Ropivacaine 0.2% (Kabi) | false | Inferred relationship | Some | ||
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | Is a | ropivacaine hydrochloride monohydrate 20 mg/10 mL injection, ampoule | false | Inferred relationship | Some | ||
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | has manufactured dose form | injection solution | false | Inferred relationship | Some | ||
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | has unit of use | ampoule | false | Inferred relationship | Some | ||
Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | has Australian BoSS | ropivacaine hydrochloride monohydrate | false | Inferred relationship | Some | 1175315839 |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ropivacaine 0.2% (Kabi) 20 mg/10 mL injection solution, 5 x 10 mL ampoules | has TPUU | False | Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | Inferred relationship | Some | |
Ropivacaine 0.2% (Kabi) 20 mg/10 mL injection solution, 5 x 10 mL ampoules | has TPUU | False | Ropivacaine 0.2% (Kabi) (ropivacaine hydrochloride monohydrate 20 mg / 10 mL) injection solution, 10 mL ampoule (trade product unit of use) | Inferred relationship | Some |
Reference Sets
Concept inactivation indicator reference set
REPLACED BY association reference set